Key facts
- Notable investors include MassChallenge, Bayer CropScience, Trendlines, Verdelis Investments.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for EcoPhage
- ·The full record, as it builds
Funding rounds
No funding rounds for EcoPhage are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EcoPhage
Operator of an agribiotechnology company intended to use bacteriophages for crop protection. The company's platform consists of a screening and characterization methodology of phage collections, resulting in the selection of the promising phage candidates providing sustainable and effective phage-based crop protection services to manage bacterial plant diseases, enabling farmers to combat fungal diseases that reduce crop production.
- Sector
- Materials and Resources
- HQ
- Ness Ziona, Israel
- Founded
- 2018
- Employees
- 11
- Website
- ecophage.com/
- Ownership
- Privately Held (backing)
EcoPhage doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EcoPhage shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EcoPhage in its N-PORT filings yet. We sweep new filings monthly.